BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34547333)

  • 1. Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats.
    Krotulski AJ; Garibay N; Walther D; Walton SE; Mohr ALA; Logan BK; Baumann MH
    Neuropharmacology; 2021 Nov; 199():108800. PubMed ID: 34547333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice.
    Glatfelter GC; Partilla JS; Baumann MH
    Neuropsychopharmacology; 2022 Mar; 47(4):924-932. PubMed ID: 34802041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking in vitro and ex vivo CB
    Janssens LK; Hudson S; Wood DM; Wolfe C; Dargan PI; Stove CP
    Arch Toxicol; 2022 Nov; 96(11):2935-2945. PubMed ID: 35962200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
    Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
    Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats.
    Walton SE; Krotulski AJ; Glatfelter GC; Walther D; Logan BK; Baumann MH
    Psychopharmacology (Berl); 2023 Jan; 240(1):185-198. PubMed ID: 36526866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists.
    Marusich JA; Gamage TF; Zhang Y; Akinfiresoye LR; Wiley JL
    Pharmacol Biochem Behav; 2022 Oct; 220():173467. PubMed ID: 36154844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and
    Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
    ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focusing on the 5F-MDMB-PICA, 4F-MDMB-BICA synthetic cannabinoids and their primary metabolites in analytical and pharmacological aspects.
    Dvorácskó S; Körmöczi T; Sija É; Bende B; Weiczner R; Varga T; Ilisz I; Institóris L; Kereszty ÉM; Tömböly C; Berkecz R
    Toxicol Appl Pharmacol; 2023 Jul; 470():116548. PubMed ID: 37182749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.
    Cabanlong CV; Russell LN; Fantegrossi WE; Prather PL
    Toxicol Sci; 2022 Apr; 187(1):175-185. PubMed ID: 35201352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl (S)-2-(1-7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography-tandem mass spectrometry).
    Szpot P; Nowak K; Wachełko O; Tusiewicz K; Chłopaś-Konowałek A; Zawadzki M
    Forensic Toxicol; 2023 Jan; 41(1):47-58. PubMed ID: 36652054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
    Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
    Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.
    Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P
    Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
    Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
    ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
    Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
    Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GC-MS/MS analysis of synthetic cannabinoids 5F-MDMB-PICA and 5F-CUMYL-PICA in forensic cases.
    Ahmed H; Mujeebuddin S
    Bioanalysis; 2024; 16(9):401-413. PubMed ID: 38466892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F-MDMB-PICA.
    Chen RJ; Zhang ZH; Yang S; Yu SC; Wang JC; Liao PY; Qiu TT; Xiao L; Xue S; Chen H; Shao WB; Hu JW; Lan Y; Chen XL; Xu Y; Zhou TM; Zhao XJ; Liu WB
    Drug Test Anal; 2024 Mar; ():. PubMed ID: 38488339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues.
    Longworth M; Banister SD; Boyd R; Kevin RC; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2017 Oct; 8(10):2159-2167. PubMed ID: 28792725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthetic cannabinoid 5F-MDMB-PICA: A case series.
    Kleis J; Germerott T; Halter S; Héroux V; Roehrich J; Schwarz CS; Hess C
    Forensic Sci Int; 2020 Sep; 314():110410. PubMed ID: 32683270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.